Role of mTOR Inhibitor Everolimus in the Treatment of Metastatic Thymic Epithelial Tumors

Patients with previously treated metastatic TETs appear to benefit from everolimus. Molecular testing of these tumors using targeted NGS panel revealed an association with several key genes, which may help to guide patient selection in the future.

Journal of Thoracic Oncology 2019